Stock analysis Epigral Limited EPIGRAL
More indepth analysis on MunafaSutra.com
Recent prices of EPIGRAL Epigral Limited are as follows: Daily volume is divided by 10 day averaged volume
Date | Close | Range | Change % | Volume |
03 Thu Apr 2025 | 1942.80 | 1911.95 to 1980.00 | -0.21% | 0.8 times |
02 Wed Apr 2025 | 1946.90 | 1877.15 to 1965.30 | 2.58% | 1.07 times |
01 Tue Apr 2025 | 1897.90 | 1875.55 to 1920.85 | -0.33% | 0.88 times |
28 Fri Mar 2025 | 1904.10 | 1877.35 to 1950.00 | -0.33% | 0.62 times |
27 Thu Mar 2025 | 1910.35 | 1852.60 to 1947.45 | 0.94% | 0.81 times |
26 Wed Mar 2025 | 1892.60 | 1865.00 to 1917.45 | 0.07% | 0.54 times |
25 Tue Mar 2025 | 1891.30 | 1880.00 to 2001.75 | -4.49% | 1.1 times |
24 Mon Mar 2025 | 1980.20 | 1917.35 to 2023.30 | 2.92% | 2.03 times |
21 Fri Mar 2025 | 1923.95 | 1902.00 to 1974.20 | 0.98% | 1.15 times |
20 Thu Mar 2025 | 1905.30 | 1873.25 to 1920.00 | 1.13% | 0.85 times |
19 Wed Mar 2025 | 1884.05 | 1831.10 to 1898.65 | 3.23% | 0.95 times |
18 Tue Mar 2025 | 1825.05 | 1773.75 to 1835.00 | 2.77% | 0.82 times |
Technical analysis forecast of Epigral Limited Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Epigral Limited EPIGRAL at this time. Stock is rising and might rise more.
It appears as if Epigral Limited EPIGRAL gave a large move recently.
Stock of Epigral Limited (EPIGRAL) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Epigral Limited is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Epigral Limited stays above 1938.5, but if it comes below 1938.5, then a intra day sell could be more profitable.
If you take a sell trade below 1938.5, then use 1938.5 as stoploss and 1869.68 as target. However if you take a buy trade in Epigral Limited, then use 1938.5 as stoploss and 2021.1 as target.